Published in Medicine and Law Weekly, June 22nd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Bayer.
Report 1: Bayer Schering Pharma AG, Germany, highlighted their expanded new offerings in Men's Healthcare during a press conference held at the 22nd Annual Meeting of the European Association of Urology (EAU) on March 22, 2007. The event focused on study results from their three products: Levitra(R), Testogel(R) and Nebido(R).
The Real-Life Perception of Efficacy, Attitude, Satisfaction and Safety of Levitra(R) Therapy (REPEAT) study (1) has been designed to help researchers...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.